nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—ABCB1—peripheral nervous system neoplasm	0.339	1	CbGaD
Olanzapine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0401	0.113	CbGbCtD
Olanzapine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0351	0.0989	CbGbCtD
Olanzapine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0351	0.0989	CbGbCtD
Olanzapine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0336	0.0948	CbGbCtD
Olanzapine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0321	0.0904	CbGbCtD
Olanzapine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0243	0.0686	CbGbCtD
Olanzapine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.021	0.0593	CbGbCtD
Olanzapine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0195	0.0551	CbGbCtD
Olanzapine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0157	0.0443	CbGbCtD
Olanzapine—HTR1D—meninx—peripheral nervous system neoplasm	0.0151	0.0904	CbGeAlD
Olanzapine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.015	0.0422	CbGbCtD
Olanzapine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0144	0.0406	CbGbCtD
Olanzapine—HTR1B—dura mater—peripheral nervous system neoplasm	0.0143	0.0859	CbGeAlD
Olanzapine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.014	0.0394	CbGbCtD
Olanzapine—HTR1D—dura mater—peripheral nervous system neoplasm	0.0139	0.0832	CbGeAlD
Olanzapine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0137	0.0387	CbGbCtD
Olanzapine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00936	0.0264	CbGbCtD
Olanzapine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00897	0.0253	CbGbCtD
Olanzapine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00882	0.0249	CbGbCtD
Olanzapine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00822	0.0232	CbGbCtD
Olanzapine—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.00809	0.0486	CbGeAlD
Olanzapine—HTR3A—vagus nerve—peripheral nervous system neoplasm	0.00686	0.0412	CbGeAlD
Olanzapine—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.00615	0.0369	CbGeAlD
Olanzapine—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.00596	0.0358	CbGeAlD
Olanzapine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00561	0.0158	CbGbCtD
Olanzapine—HTR3A—cranial nerve—peripheral nervous system neoplasm	0.00523	0.0314	CbGeAlD
Olanzapine—HTR7—vagus nerve—peripheral nervous system neoplasm	0.00444	0.0266	CbGeAlD
Olanzapine—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.00438	0.0263	CbGeAlD
Olanzapine—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00424	0.0255	CbGeAlD
Olanzapine—HTR6—ganglion—peripheral nervous system neoplasm	0.00368	0.0221	CbGeAlD
Olanzapine—DRD5—ganglion—peripheral nervous system neoplasm	0.00358	0.0215	CbGeAlD
Olanzapine—HTR7—cranial nerve—peripheral nervous system neoplasm	0.00338	0.0203	CbGeAlD
Olanzapine—HTR7—pons—peripheral nervous system neoplasm	0.00334	0.0201	CbGeAlD
Olanzapine—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00296	0.0178	CbGeAlD
Olanzapine—DRD1—nerve—peripheral nervous system neoplasm	0.00277	0.0166	CbGeAlD
Olanzapine—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00277	0.0166	CbGeAlD
Olanzapine—DRD1—ganglion—peripheral nervous system neoplasm	0.00274	0.0164	CbGeAlD
Olanzapine—HTR3A—nerve—peripheral nervous system neoplasm	0.00268	0.0161	CbGeAlD
Olanzapine—HTR3A—ganglion—peripheral nervous system neoplasm	0.00265	0.0159	CbGeAlD
Olanzapine—HTR1B—ganglion—peripheral nervous system neoplasm	0.00222	0.0133	CbGeAlD
Olanzapine—HTR1D—ganglion—peripheral nervous system neoplasm	0.00215	0.0129	CbGeAlD
Olanzapine—HTR2C—ganglion—peripheral nervous system neoplasm	0.00213	0.0128	CbGeAlD
Olanzapine—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00211	0.0127	CbGeAlD
Olanzapine—HTR2A—pons—peripheral nervous system neoplasm	0.00208	0.0125	CbGeAlD
Olanzapine—HTR1E—brainstem—peripheral nervous system neoplasm	0.00204	0.0122	CbGeAlD
Olanzapine—HTR1A—ganglion—peripheral nervous system neoplasm	0.00179	0.0107	CbGeAlD
Olanzapine—FMO3—parotid gland—peripheral nervous system neoplasm	0.00175	0.0105	CbGeAlD
Olanzapine—HTR7—nerve—peripheral nervous system neoplasm	0.00173	0.0104	CbGeAlD
Olanzapine—HTR7—ganglion—peripheral nervous system neoplasm	0.00171	0.0103	CbGeAlD
Olanzapine—DRD2—nerve—peripheral nervous system neoplasm	0.00164	0.00983	CbGeAlD
Olanzapine—DRD2—ganglion—peripheral nervous system neoplasm	0.00162	0.00971	CbGeAlD
Olanzapine—H1F0—trigeminal ganglion—peripheral nervous system neoplasm	0.00136	0.00818	CbGeAlD
Olanzapine—HTR3A—trigeminal ganglion—peripheral nervous system neoplasm	0.0013	0.0078	CbGeAlD
Olanzapine—H1F0—parotid gland—peripheral nervous system neoplasm	0.00128	0.00771	CbGeAlD
Olanzapine—DRD1—brainstem—peripheral nervous system neoplasm	0.00119	0.00715	CbGeAlD
Olanzapine—HTR3A—brainstem—peripheral nervous system neoplasm	0.00115	0.0069	CbGeAlD
Olanzapine—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00109	0.00654	CbGeAlD
Olanzapine—HTR2A—nerve—peripheral nervous system neoplasm	0.00108	0.00649	CbGeAlD
Olanzapine—HTR2A—ganglion—peripheral nervous system neoplasm	0.00107	0.00641	CbGeAlD
Olanzapine—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.00106	0.00633	CbGeAlD
Olanzapine—HTR1B—brainstem—peripheral nervous system neoplasm	0.000965	0.00579	CbGeAlD
Olanzapine—HTR1D—brainstem—peripheral nervous system neoplasm	0.000934	0.00561	CbGeAlD
Olanzapine—CHRM1—parotid gland—peripheral nervous system neoplasm	0.000931	0.00559	CbGeAlD
Olanzapine—HTR2C—brainstem—peripheral nervous system neoplasm	0.000925	0.00555	CbGeAlD
Olanzapine—HTR1A—brainstem—peripheral nervous system neoplasm	0.000778	0.00467	CbGeAlD
Olanzapine—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.000773	0.00464	CbGeAlD
Olanzapine—HTR7—brainstem—peripheral nervous system neoplasm	0.000744	0.00447	CbGeAlD
Olanzapine—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.000729	0.00437	CbGeAlD
Olanzapine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000718	0.00431	CbGeAlD
Olanzapine—DRD2—brainstem—peripheral nervous system neoplasm	0.000703	0.00422	CbGeAlD
Olanzapine—HRH1—trigeminal ganglion—peripheral nervous system neoplasm	0.000628	0.00377	CbGeAlD
Olanzapine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000617	0.0037	CbGeAlD
Olanzapine—H1F0—cerebellum—peripheral nervous system neoplasm	0.000594	0.00357	CbGeAlD
Olanzapine—HTR2A—brainstem—peripheral nervous system neoplasm	0.000464	0.00278	CbGeAlD
Olanzapine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000423	0.00254	CbGeAlD
Olanzapine—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000384	0.0023	CbGeAlD
Olanzapine—HTR7—cerebellum—peripheral nervous system neoplasm	0.000367	0.0022	CbGeAlD
Olanzapine—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000354	0.00212	CbGeAlD
Olanzapine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000347	0.00208	CbGeAlD
Olanzapine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000344	0.00206	CbGeAlD
Olanzapine—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.000337	0.00202	CbGeAlD
Olanzapine—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000269	0.00161	CbGeAlD
Olanzapine—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000229	0.00137	CbGeAlD
Olanzapine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000208	0.00125	CbGeAlD
Olanzapine—ABCB1—cerebellum—peripheral nervous system neoplasm	0.00015	0.0009	CbGeAlD
Olanzapine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.14e-05	8.16e-05	CbGpPWpGaD
Olanzapine—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.14e-05	8.15e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.14e-05	8.11e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.14e-05	8.11e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.13e-05	8.1e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.13e-05	8.08e-05	CbGpPWpGaD
Olanzapine—CHRM5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.13e-05	8.07e-05	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.13e-05	8.06e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.13e-05	8.05e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.13e-05	8.05e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.12e-05	8.03e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.12e-05	8.02e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.12e-05	8.01e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.12e-05	7.99e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.12e-05	7.99e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.12e-05	7.98e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.12e-05	7.96e-05	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.11e-05	7.94e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.11e-05	7.91e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.11e-05	7.9e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.1e-05	7.89e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.1e-05	7.88e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.1e-05	7.88e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.1e-05	7.87e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.1e-05	7.86e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.1e-05	7.85e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.1e-05	7.83e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.1e-05	7.82e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.09e-05	7.8e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.09e-05	7.75e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.08e-05	7.74e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.08e-05	7.72e-05	CbGpPWpGaD
Olanzapine—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.08e-05	7.69e-05	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	1.08e-05	7.68e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.07e-05	7.65e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.07e-05	7.62e-05	CbGpPWpGaD
Olanzapine—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.06e-05	7.58e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.05e-05	7.52e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.05e-05	7.47e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.04e-05	7.42e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.04e-05	7.41e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.04e-05	7.4e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.04e-05	7.4e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.03e-05	7.36e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.03e-05	7.35e-05	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	1.03e-05	7.35e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.03e-05	7.33e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.02e-05	7.3e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.01e-05	7.22e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.01e-05	7.21e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.01e-05	7.18e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.01e-05	7.18e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.93e-06	7.09e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.91e-06	7.07e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.87e-06	7.04e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.85e-06	7.03e-05	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.82e-06	7.01e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.8e-06	7e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.78e-06	6.98e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.78e-06	6.98e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.68e-06	6.91e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.67e-06	6.9e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.65e-06	6.89e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.63e-06	6.87e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.6e-06	6.86e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	9.6e-06	6.85e-05	CbGpPWpGaD
Olanzapine—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.59e-06	6.85e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	9.55e-06	6.82e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.52e-06	6.8e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.5e-06	6.78e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.48e-06	6.77e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.47e-06	6.76e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.4e-06	6.71e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.38e-06	6.7e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	9.37e-06	6.69e-05	CbGpPWpGaD
Olanzapine—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.26e-06	6.61e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.25e-06	6.61e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.22e-06	6.58e-05	CbGpPWpGaD
Olanzapine—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.21e-06	6.58e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.17e-06	6.55e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.16e-06	6.54e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.13e-06	6.52e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.13e-06	6.52e-05	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	9.09e-06	6.49e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.07e-06	6.47e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	9.03e-06	6.44e-05	CbGpPWpGaD
Olanzapine—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.96e-06	6.4e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.94e-06	6.38e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.88e-06	6.34e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.87e-06	6.34e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.83e-06	6.31e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.82e-06	6.3e-05	CbGpPWpGaD
Olanzapine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.82e-06	6.3e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.75e-06	6.25e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.74e-06	6.24e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.74e-06	6.24e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.73e-06	6.23e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.71e-06	6.22e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.71e-06	6.22e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.69e-06	6.21e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.69e-06	6.2e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.66e-06	6.18e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.57e-06	6.12e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.55e-06	6.1e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.41e-06	6e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.37e-06	5.97e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.36e-06	5.97e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.33e-06	5.95e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.23e-06	5.87e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.22e-06	5.87e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.21e-06	5.86e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.18e-06	5.84e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.16e-06	5.82e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.14e-06	5.81e-05	CbGpPWpGaD
Olanzapine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.13e-06	5.8e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.08e-06	5.77e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.06e-06	5.75e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.06e-06	5.75e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.01e-06	5.72e-05	CbGpPWpGaD
Olanzapine—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8e-06	5.71e-05	CbGpPWpGaD
Olanzapine—HRH1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.98e-06	5.7e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.97e-06	5.69e-05	CbGpPWpGaD
Olanzapine—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.96e-06	5.68e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.95e-06	5.67e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.94e-06	5.67e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.94e-06	5.67e-05	CbGpPWpGaD
Olanzapine—CHRM3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.93e-06	5.66e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.93e-06	5.66e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.91e-06	5.65e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.89e-06	5.63e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.88e-06	5.63e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.86e-06	5.61e-05	CbGpPWpGaD
Olanzapine—CHRM2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.85e-06	5.61e-05	CbGpPWpGaD
Olanzapine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.83e-06	5.59e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.78e-06	5.56e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.76e-06	5.54e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.72e-06	5.51e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.69e-06	5.49e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.65e-06	5.46e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.6e-06	5.43e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.6e-06	5.42e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.59e-06	5.42e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.54e-06	5.38e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.5e-06	5.35e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.49e-06	5.34e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.44e-06	5.31e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.42e-06	5.3e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.39e-06	5.27e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.38e-06	5.27e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	7.37e-06	5.26e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.32e-06	5.23e-05	CbGpPWpGaD
Olanzapine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.28e-06	5.2e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.27e-06	5.19e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.26e-06	5.19e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.25e-06	5.18e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.25e-06	5.17e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	7.23e-06	5.16e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.23e-06	5.16e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.21e-06	5.15e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.2e-06	5.14e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.18e-06	5.12e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.17e-06	5.12e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.16e-06	5.11e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.13e-06	5.09e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.13e-06	5.09e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.11e-06	5.08e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.94e-06	4.95e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.93e-06	4.95e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.87e-06	4.9e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.84e-06	4.88e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.82e-06	4.87e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.75e-06	4.82e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.75e-06	4.82e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.71e-06	4.79e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.7e-06	4.79e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.66e-06	4.75e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.64e-06	4.74e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.63e-06	4.73e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.61e-06	4.72e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.61e-06	4.72e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.59e-06	4.7e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.54e-06	4.67e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.52e-06	4.66e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.52e-06	4.66e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.5e-06	4.64e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.46e-06	4.61e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.42e-06	4.58e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.33e-06	4.52e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.29e-06	4.49e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.19e-06	4.42e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.17e-06	4.41e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.16e-06	4.39e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.14e-06	4.38e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.13e-06	4.37e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.09e-06	4.35e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.08e-06	4.34e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.06e-06	4.33e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.06e-06	4.33e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.04e-06	4.31e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.88e-06	4.2e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.85e-06	4.18e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.83e-06	4.16e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.78e-06	4.12e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	5.75e-06	4.1e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.7e-06	4.07e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.69e-06	4.06e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.63e-06	4.02e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.63e-06	4.02e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.6e-06	4e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.6e-06	4e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.44e-06	3.89e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.36e-06	3.82e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.16e-06	3.69e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.15e-06	3.67e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—AKT1—peripheral nervous system neoplasm	5.09e-06	3.63e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.08e-06	3.63e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.07e-06	3.62e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.05e-06	3.61e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.04e-06	3.6e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.99e-06	3.56e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.98e-06	3.55e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.97e-06	3.55e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.94e-06	3.53e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.94e-06	3.53e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.86e-06	3.47e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.85e-06	3.46e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.83e-06	3.45e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.82e-06	3.44e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.81e-06	3.43e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.77e-06	3.41e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.76e-06	3.4e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.73e-06	3.38e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	4.67e-06	3.33e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.62e-06	3.3e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.42e-06	3.16e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.36e-06	3.11e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.29e-06	3.06e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.28e-06	3.06e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.27e-06	3.05e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.25e-06	3.04e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.21e-06	3.01e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.2e-06	3e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.9e-06	2.79e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	3.68e-06	2.63e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	3.31e-06	2.36e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	3.23e-06	2.3e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	3.04e-06	2.17e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	3.02e-06	2.15e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.58e-06	1.84e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.99e-06	1.42e-05	CbGpPWpGaD
